An international team led by two Université de Montréal researchers has unveiled how a molecule capable of opening the "shell ...

A first encounter with the dengue virus typically causes very mild symptoms; however, a subsequent infection is a different story. For a small proportion of people who are reinfected, the virus can ...

By blocking a molecule that pushes the immune system into overdrive, a vaccine protects mice from life-threatening ...

The antibody's altered structure helps explain an enduring mystery of dengue -- why only a fraction of those infected will develop severe disease. A first encounter with the dengue virus typically ...

A study by a multidisciplinary team of researchers from The Saban Research Institute of Children's Hospital Los Angeles sheds further light on the role of the cytokine TGFβ1 in the growth of ...

J&J is also running mid-stage trials of a tau active immunotherapy codenamed JNJ-2056 for Alzheimer's, while other active tau ...

Japanese drug firm Chugai Pharmaceutical has established competitive advantages due to its alliance with majority shareholder Roche as well as its internal research and development engine. While ...

The global monoclonal antibody for asthma and COPD market size was valued at USD 34.02 billion in 2025 and is predicted to ...